PYXS
Price
$0.91
Change
-$0.03 (-3.19%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
57.62M
35 days until earnings call
RXRX
Price
$4.24
Change
-$0.57 (-11.85%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.93B
33 days until earnings call
Ad is loading...

PYXS vs RXRX

Header iconPYXS vs RXRX Comparison
Open Charts PYXS vs RXRXBanner chart's image
Pyxis Oncology
Price$0.91
Change-$0.03 (-3.19%)
Volume$11.78K
Capitalization57.62M
Recursion Pharmaceuticals
Price$4.24
Change-$0.57 (-11.85%)
Volume$208.06K
Capitalization1.93B
PYXS vs RXRX Comparison Chart
Loading...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PYXS vs. RXRX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYXS is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (PYXS: $0.94 vs. RXRX: $4.81)
Brand notoriety: PYXS and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYXS: 70% vs. RXRX: 74%
Market capitalization -- PYXS: $57.62M vs. RXRX: $1.93B
PYXS [@Biotechnology] is valued at $57.62M. RXRX’s [@Biotechnology] market capitalization is $1.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYXS’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PYXS’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both PYXS and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYXS’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PYXS’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than RXRX.

Price Growth

PYXS (@Biotechnology) experienced а -14.17% price change this week, while RXRX (@Biotechnology) price change was -19.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

PYXS is expected to report earnings on May 09, 2025.

RXRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.93B) has a higher market cap than PYXS($57.6M). RXRX YTD gains are higher at: -28.846 vs. PYXS (-40.032). PYXS has higher annual earnings (EBITDA): -64.04M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. PYXS (145M). PYXS has less debt than RXRX: PYXS (20.5M) vs RXRX (108M). RXRX has higher revenues than PYXS: RXRX (58.5M) vs PYXS (16.1M).
PYXSRXRXPYXS / RXRX
Capitalization57.6M1.93B3%
EBITDA-64.04M-426.72M15%
Gain YTD-40.032-28.846139%
P/E RatioN/AN/A-
Revenue16.1M58.5M28%
Total Cash145M594M24%
Total Debt20.5M108M19%
TECHNICAL ANALYSIS
Technical Analysis
PYXSRXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTNA33.280.70
+2.15%
Artesian Resources Corp
BUD62.900.80
+1.29%
Anheuser-Busch INBEV SA/NV
LPG20.12-1.69
-7.75%
DORIAN LPG Ltd
CHX27.64-2.37
-7.90%
ChampionX Corp
SHFS2.46-0.68
-21.66%
SHF Holdings Inc

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-8.28%
KURA - PYXS
65%
Loosely correlated
-5.37%
CTMX - PYXS
39%
Loosely correlated
-10.78%
BLRX - PYXS
39%
Loosely correlated
-5.16%
ABOS - PYXS
39%
Loosely correlated
-8.52%
RXRX - PYXS
36%
Loosely correlated
-9.07%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-9.07%
CRSP - RXRX
69%
Closely correlated
-4.47%
BEAM - RXRX
63%
Loosely correlated
-10.93%
NTLA - RXRX
58%
Loosely correlated
-5.62%
ABSI - RXRX
56%
Loosely correlated
-9.88%
PRME - RXRX
56%
Loosely correlated
-10.06%
More